サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：医用画像解析ソフトウェア市場：世界の市場規模、シェア、動向分析、機会、予測レポート、2019-2029年
市場調査レポート
商品コード
1301831

医用画像解析ソフトウェア市場：世界の市場規模、シェア、動向分析、機会、予測レポート、2019-2029年

Medical Image Analysis Software Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Software ; By Modality ; By Imaging ; By Application ; By End User ; By Region
出版日: | 発行: Blueweave Consulting | ページ情報: 英文 400 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
医用画像解析ソフトウェア市場：世界の市場規模、シェア、動向分析、機会、予測レポート、2019-2029年
出版日: 2023年06月30日
発行: Blueweave Consulting
ページ情報: 英文 400 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

医用画像解析ソフトウェアの世界市場規模は2029年までに56億2,000万米ドルを超える

世界の医用画像解析ソフトウェア市場は、特に難治性疾患の迅速な診断のための超音波画像診断装置の使用の増加や、マルチモダリティイメージングプラットフォームや3Dイメージングなどの技術的に高度な医療用画像装置の採用の増加により、活況を呈しています。

戦略コンサルティングと市場調査の大手企業であるBlueWeave Consultingは、最近の調査で、2022年の世界の医用画像解析ソフトウェア市場規模を33億米ドルと推定しました。2023年から2029年の予測期間中、BlueWeaveは世界の医用画像解析ソフトウェア市場規模がCAGR 7.80%で成長し、2029年には56億2,000万米ドルに達すると予測しています。特に難治性疾患の迅速な診断のために超音波画像診断装置の使用が増加していることが、医用画像解析ソフトウェアの需要を牽引していると考えられます。マルチモダリティ・イメージング・プラットフォームや3Dイメージングなど、技術的に先進的な製品の採用が増加していることに加え、高解像度イメージング、使いやすさ、柔軟性など、これらのシステムを使用する利点が消費者の需要増加を後押ししています。高齢者人口の増加により、慢性疾患の数が増加しています。このような疾患の有病率の増加は、画像診断技術の使用を増加させ、医用画像解析ソフトウェアの市場を強化する可能性があります。

本レポートの詳細な分析により、成長の可能性、今後の動向、世界の医用画像解析ソフトウェア市場の統計に関する情報を提供します。また、総市場規模の予測を促進する要因も取り上げています。当レポートは、世界の医用画像解析ソフトウェア市場の最新技術動向と業界洞察を提供し、意思決定者が健全な戦略的意思決定を行えるよう支援します。さらに、市場の成長促進要因・課題・競争力学についても分析しています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界の医用画像解析ソフトウェア市場に関する洞察

  • 業界のバリューチェーン分析
  • DROC分析
    • 成長の原動力
      • 慢性疾患の有病率の増加
      • 医用画像解析ソフトウェアへのAIの搭載
      • 効率性と効果性に対するニーズの高まり
    • 抑制要因
      • 予算の制約
      • ソフトウェアのコンプライアンスとセキュリティに対する懸念の高まり
    • 機会
      • 技術の進歩
    • 課題
      • 熟練した専門家の不足
  • 技術の進歩/最近の開発
  • 規制の枠組み
  • ポーターのファイブフォース分析

第4章 世界の医用画像解析ソフトウェア市場概要

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • ソフトウェア別
      • 統合ソフトウェア
      • スタンドアロンソフトウェア
    • モダリティ別
      • 断層撮影
      • コンピュータ断層撮影
      • 磁気共鳴画像
      • 陽電子放出断層撮影
      • 単光子放射断層撮影法
      • 超音波画像診断
      • 放射線画像撮影
      • 複合モダリティ
    • イメージング別
      • 2Dイメージング
      • 3Dイメージング
      • 4Dイメージング
    • 用途別
      • 整形外科
      • 歯科
      • 神経内科
      • 心臓病学
      • 腫瘍学
      • 産婦人科
      • マンモグラフィー
      • 泌尿器科と腎臓科
    • 最終用途別
      • 病院
      • 診断センター
      • 外来手術センター（ASC）
      • その他（学術研究センター）
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋（APAC）
      • ラテンアメリカ（LATAM）
      • 中東およびアフリカ（MEA）

第5章 北米の医用画像解析ソフトウェア市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • ソフトウェア別
    • モダリティ別
    • イメージング別
    • 用途別
    • エンドユーザー別
    • 国別
      • 米国
      • カナダ

第6章 欧州の医用画像解析ソフトウェア市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • ソフトウェア別
    • モダリティ別
    • イメージング別
    • 用途別
    • エンドユーザー別
    • 国別
      • ドイツ
      • 英国
      • イタリア
      • フランス
      • スペイン
      • ベルギー
      • ロシア
      • オランダ
      • その他欧州

第7章 アジア太平洋の医用画像解析ソフトウェア市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • ソフトウェア別
    • モダリティ別
    • イメージング別
    • 用途別
    • エンドユーザー別
    • 国別
      • 中国
      • インド
      • 日本
      • 韓国
      • オーストラリアとニュージーランド
      • インドネシア
      • マレーシア
      • シンガポール
      • ベトナム
      • APACのその他諸国

第8章 ラテンアメリカの医用画像解析ソフトウェア市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • ソフトウェア別
    • モダリティ別
    • イメージング別
    • 用途別
    • エンドユーザー別
    • 国別
      • ブラジル
      • メキシコ
      • アルゼンチン
      • ペルー
      • 中南米の残りの地域

第9章 中東およびアフリカの医用画像解析ソフトウェア市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • ソフトウェア別
    • モダリティ別
    • イメージング別
    • 用途別
    • エンドユーザー別
    • 国別
      • サウジアラビア
      • アラブ首長国連邦
      • カタール
      • クウェート
      • 南アフリカ
      • ナイジェリア
      • アルジェリア
      • MEAの残りの部分

第10章 競合情勢

  • 主要企業とその製品のリスト
  • 世界の医用画像解析ソフトウェア企業の市場シェア分析、2022年
  • 経営パラメータ別競合ベンチマーキング
  • 主要な戦略的展開（合併、買収、パートナーシップなど）

第11章 世界の医用画像解析ソフトウェア市場に対するCOVID-19の影響

第12章 企業プロファイル（会社概要、財務マトリックス、競合情勢、主要な人材、主要な競合、連絡先住所、戦略的展望、 SWOT分析）

  • Toshiba Medical Systems Corp.
  • Bruker Corp.
  • Xinapse Systems Ltd.
  • Esaote, Inc.
  • ClaroNAv, Inc.
  • Merge Healthcare Inc.
  • Aquilab GmbH
  • Spacelabs Healthcare, Inc.
  • MIM Software Inc.
  • Carestream Health, Inc.
  • Agfa-Gevaert Corp.
  • Philips Healthcare
  • Siemens Healthineers
  • GE Healthcare
  • Other Prominent Players

第13章 主要な戦略的推奨事項

第14章 調査手法

  • 定性的調査
    • 一次および2次調査
  • 定量的調査
  • 市場内訳とデータの三角測量
    • 2次調査
    • 1次調査
  • 1次調査回答者の地域別内訳
  • 前提と制限
目次
Product Code: BWC23522

Global Medical Image Analysis Software Market Size Set to Cross USD 5.62 Billion by 2029

Global medical image analysis software market is flourishing due to the increasing use of ultrasonic imaging equipment for faster diagnosis, particularly of persistent illnesses, and the growing adoption of technologically advanced medical image equipment, such as multimodality imaging platforms and 3D imaging.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global medical image analysis software market size at USD 3.30 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global medical image analysis software market size to grow at a CAGR of 7.80% reaching a value of USD 5.62 billion by 2029. The increasing use of ultrasonic imaging equipment for faster diagnosis, particularly of persistent illnesses, is likely to drive the demand for medical image analysis software. The increasing adoption of technologically advanced products, such as multimodality imaging platforms and 3D imaging, as well as the benefits of using these systems, such as high-resolution imaging, ease of use, and flexibility, is driving rising consumer demand. The growing elderly population has increased the number of chronic diseases. The rising prevalence of such disorders may increase the use of diagnostic imaging technologies, enhancing the market for medical imaging analysis software.

Opportunity: Introduction of CT-guided diagnosis

Radiation exposure for patients and medical staff has gradually increased with the advent of CT-guided diagnosis and intervention, including nuclear medicine-based scans and angiography. As a result, statutory organizations have made it essential for patients' radiation exposure to be monitored and reported in their medical records. It is also crucial to monitor how much radiation doctors are exposed to while performing their duties. For instance, DoseWatch is a program offered by GE to keep track of the radiation doses supplied to patients at a certain facility. Data can be categorized according to devices, protocols, or operators to make it easier to find dose outliers. Sectra provides web-based dose tracking. Sectra is attributed by the American College of Radiology and may transmit dosage data directly from a hospital to its Dose Index Registry. Therefore, the increasing number of the introduction of CT-guided diagnosis is expected to create lucrative opportunities for the growth of the global medical image analysis software market in the coming years.

Restraint: Budgetary constraints

The global medical image analysis software market is projected to encounter budgetary constraints, due to a variety of factors, including limited funding for healthcare R&D, the high cost of developing and maintaining these software solutions, and by healthcare providers and organizations. The high cost of developing and sustaining these solutions is one of the major constraints for medical image analysis software suppliers. The development of these software solutions requires significant R&D investment, including the expense of employing trained individuals, developing and testing algorithms, and gathering high-quality imaging data. The ongoing maintenance and support of these software solutions can be expensive. These factors may hamper market growth in the coming years.

Impact of COVID-19 on Global Medical Image Analysis Software Market

The global medical image analysis software market was significantly impacted by the COVID-19 pandemic. Considering the importance of medical imaging in diagnosing and treating severe COVID-19 infections, the medical imaging sector witnessed considerable growth during the COVID-19 pandemic. Medical imaging software methods are also used in the care of COVID-19 patients. Chest X-rays, CT scans, and ultrasonography were commonly used to identify the extent of COVID-19 infections and the disease's progress in the lungs. All of these factors led to a rise in global market demand. Thus, the COVID-19 pandemic positively impacted the global medical image analysis software market growth.

Global Medical Image Analysis Software Market - By Application:

Based on application, the global medical image analysis software market is divided into orthopedic, dental, neurology, cardiology, oncology, obstetrics & gynecology, mammography, and urology & nephrology segments. Neurology is expected to be the fastest-growing application segment during the forecast period, due to a rising incidence of brain cancer, tumors, and other brain-related ailments, which is expected to drive the market growth for medical image analysis software over the forecast period. The increased emphasis on the most recent technological advances in the medical industry has a significant impact on the market expansion.

Global Medical Image Analysis Software Market - By End User:

Based on end user, the global medical image analysis software market is segmented into hospitals, diagnostic centers, ambulatory surgical centers (ASCS), and others (academic & research centers). The hospitals segment dominated the market and accounted for a significant market share. Supportive infrastructure, which is essential in performing surgical interventions using medical imaging software, is one of the important reasons for supporting the segment's expansion. Hospitals have a larger installed base of diagnostic imaging systems and solutions than research and diagnostic centers. Patient inflow is significantly higher. It keeps the end-use portion in the first place.

Global Medical Image Analysis Software Market - By Region:

Asia Pacific is expected to grow significantly in the global medical image analysis software market during the period in analysis. Rising investments in healthcare, improved healthcare infrastructure, and increasing adoption of medical imaging devices, AI, and telehealth services are expected to drive the growth of this regional market. Economic development in APAC has greatly boosted access to healthcare and improved healthcare infrastructure. The region's healthcare sector is expected to undergo significant change over the next five years.

Competitive Landscape:

The global medical image analysis software market is highly competitive, with all the players continually competing to gain a larger market share. Key players in the market include Toshiba Medical Systems Corp., Bruker Corp., Xinapse Systems Ltd., Esaote, Inc., ClaroNAv, Inc., Merge Healthcare Inc., Aquilab GmbH, Spacelabs Healthcare, Inc., MIM Software Inc., Carestream Health, Inc., Agfa-Gevaert Corp., Philips Healthcare, Siemens Healthineers, and GE Healthcare.

The report's in-depth analysis provides information about growth potential, upcoming trends, and the Global Medical Image Analysis Software Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the global Global Medical image analysis software Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Medical Image Analysis Software Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Prevalence of Chronic Diseases
      • 3.2.1.2. Incorporation of AI in Medical Image Analysis Software
      • 3.2.1.3. Rising Need for Efficiency and Effectiveness
    • 3.2.2. Restraints
      • 3.2.2.1. Budgetary Constraints
      • 3.2.2.2. Increasing Concern Regarding the Compliance and Security of Software
    • 3.2.3. Opportunities
      • 3.2.3.1. Advancement in technology
    • 3.2.4. Challenges
      • 3.2.4.1. Lack of Skilled Professionals
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Medical Image Analysis Software Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Software
      • 4.2.1.1. Integrated Software
      • 4.2.1.2. Stand-alone Software
    • 4.2.2. By Modality
      • 4.2.2.1. Tomography
      • 4.2.2.1.1. Computed Tomography
      • 4.2.2.1.2. Magnetic Resonance Imaging
      • 4.2.2.1.3. Positron Emission Tomography
      • 4.2.2.1.4. Single-Photon Emission Tomography
      • 4.2.2.2. Ultrasound Imaging
      • 4.2.2.3. Radiographic Imaging
      • 4.2.2.4. Combined Modalities
    • 4.2.3. By Imaging
      • 4.2.3.1. 2D Imaging
      • 4.2.3.2. 3D Imaging
      • 4.2.3.3. 4D Imaging
    • 4.2.4. By Application
      • 4.2.4.1. Orthopedic
      • 4.2.4.2. Dental
      • 4.2.4.3. Neurology
      • 4.2.4.4. Cardiology
      • 4.2.4.5. Oncology
      • 4.2.4.6. Obstetrics & Gynecology
      • 4.2.4.7. Mammography
      • 4.2.4.8. Urology & Nephrology
    • 4.2.5. By End Use
      • 4.2.5.1. Hospitals
      • 4.2.5.2. Diagnostic Centers
      • 4.2.5.3. Ambulatory Surgical Centers (ASCs)
      • 4.2.5.4. Others (Academic & Research Centers)
    • 4.2.6. By Region
      • 4.2.6.1. North America
      • 4.2.6.2. Europe
      • 4.2.6.3. Asia Pacific (APAC)
      • 4.2.6.4. Latin America (LATAM)
      • 4.2.6.5. Middle East and Africa (MEA)

5. North America Medical Image Analysis Software Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Software
    • 5.2.2. By Modality
    • 5.2.3. By Imaging
    • 5.2.4. By Application
    • 5.2.5. By End User
    • 5.2.6. By Country
      • 5.2.6.1. United States
      • 5.2.6.1.1. By Software
      • 5.2.6.1.2. By Modality
      • 5.2.6.1.3. By Imaging
      • 5.2.6.1.4. By Application
      • 5.2.6.1.5. By End User
      • 5.2.6.2. Canada
      • 5.2.6.2.1. By Software
      • 5.2.6.2.2. By Modality
      • 5.2.6.2.3. By Imaging
      • 5.2.6.2.4. By Application
      • 5.2.6.2.5. By End User

6. Europe Medical Image Analysis Software Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Software
    • 6.2.2. By Modality
    • 6.2.3. By Imaging
    • 6.2.4. By Application
    • 6.2.5. By End User
    • 6.2.6. By Country
      • 6.2.6.1. Germany
      • 6.2.6.1.1. By Software
      • 6.2.6.1.2. By Modality
      • 6.2.6.1.3. By Imaging
      • 6.2.6.1.4. By Application
      • 6.2.6.1.5. By End User
      • 6.2.6.2. United Kingdom
      • 6.2.6.2.1. By Software
      • 6.2.6.2.2. By Modality
      • 6.2.6.2.3. By Imaging
      • 6.2.6.2.4. By Application
      • 6.2.6.2.5. By End User
      • 6.2.6.3. Italy
      • 6.2.6.3.1. By Software
      • 6.2.6.3.2. By Modality
      • 6.2.6.3.3. By Imaging
      • 6.2.6.3.4. By Application
      • 6.2.6.3.5. By End User
      • 6.2.6.4. France
      • 6.2.6.4.1. By Software
      • 6.2.6.4.2. By Modality
      • 6.2.6.4.3. By Imaging
      • 6.2.6.4.4. By Application
      • 6.2.6.4.5. By End User
      • 6.2.6.5. Spain
      • 6.2.6.5.1. By Software
      • 6.2.6.5.2. By Modality
      • 6.2.6.5.3. By Imaging
      • 6.2.6.5.4. By Application
      • 6.2.6.5.5. By End User
      • 6.2.6.6. Belgium
      • 6.2.6.6.1. By Software
      • 6.2.6.6.2. By Modality
      • 6.2.6.6.3. By Imaging
      • 6.2.6.6.4. By Application
      • 6.2.6.6.5. By End User
      • 6.2.6.7. Russia
      • 6.2.6.7.1. By Software
      • 6.2.6.7.2. By Modality
      • 6.2.6.7.3. By Imaging
      • 6.2.6.7.4. By Application
      • 6.2.6.7.5. By End User
      • 6.2.6.8. The Netherlands
      • 6.2.6.8.1. By Software
      • 6.2.6.8.2. By Modality
      • 6.2.6.8.3. By Imaging
      • 6.2.6.8.4. By Application
      • 6.2.6.8.5. By End User
      • 6.2.6.9. Rest of Europe
      • 6.2.6.9.1. By Software
      • 6.2.6.9.2. By Modality
      • 6.2.6.9.3. By Imaging
      • 6.2.6.9.4. By Application
      • 6.2.6.9.5. By End User

7. Asia-Pacific Medical Image Analysis Software Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Software
    • 7.2.2. By Modality
    • 7.2.3. By Imaging
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
      • 7.2.6.1. China
      • 7.2.6.1.1. By Software
      • 7.2.6.1.2. By Modality
      • 7.2.6.1.3. By Imaging
      • 7.2.6.1.4. By Application
      • 7.2.6.1.5. By End User
      • 7.2.6.2. India
      • 7.2.6.2.1. By Software
      • 7.2.6.2.2. By Modality
      • 7.2.6.2.3. By Imaging
      • 7.2.6.2.4. By Application
      • 7.2.6.2.5. By End User
      • 7.2.6.3. Japan
      • 7.2.6.3.1. By Software
      • 7.2.6.3.2. By Modality
      • 7.2.6.3.3. By Imaging
      • 7.2.6.3.4. By Application
      • 7.2.6.3.5. By End User
      • 7.2.6.4. South Korea
      • 7.2.6.4.1. By Software
      • 7.2.6.4.2. By Modality
      • 7.2.6.4.3. By Imaging
      • 7.2.6.4.4. By Application
      • 7.2.6.4.5. By End User
      • 7.2.6.5. Australia & New Zealand
      • 7.2.6.5.1. By Software
      • 7.2.6.5.2. By Modality
      • 7.2.6.5.3. By Imaging
      • 7.2.6.5.4. By Application
      • 7.2.6.5.5. By End User
      • 7.2.6.6. Indonesia
      • 7.2.6.6.1. By Software
      • 7.2.6.6.2. By Modality
      • 7.2.6.6.3. By Imaging
      • 7.2.6.6.4. By Application
      • 7.2.6.6.5. By End User
      • 7.2.6.7. Malaysia
      • 7.2.6.7.1. By Software
      • 7.2.6.7.2. By Modality
      • 7.2.6.7.3. By Imaging
      • 7.2.6.7.4. By Application
      • 7.2.6.7.5. By End User
      • 7.2.6.8. Singapore
      • 7.2.6.8.1. By Software
      • 7.2.6.8.2. By Modality
      • 7.2.6.8.3. By Imaging
      • 7.2.6.8.4. By Application
      • 7.2.6.8.5. By End User
      • 7.2.6.9. Vietnam
      • 7.2.6.9.1. By Software
      • 7.2.6.9.2. By Modality
      • 7.2.6.9.3. By Imaging
      • 7.2.6.9.4. By Application
      • 7.2.6.9.5. By End User
      • 7.2.6.10. Rest of APAC
      • 7.2.6.10.1. By Software
      • 7.2.6.10.2. By Modality
      • 7.2.6.10.3. By Imaging
      • 7.2.6.10.4. By Application
      • 7.2.6.10.5. By End User

8. Latin America Medical Image Analysis Software Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Software
    • 8.2.2. By Modality
    • 8.2.3. By Imaging
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
      • 8.2.6.1. Brazil
      • 8.2.6.1.1. By Software
      • 8.2.6.1.2. By Modality
      • 8.2.6.1.3. By Imaging
      • 8.2.6.1.4. By Application
      • 8.2.6.1.5. By End User
      • 8.2.6.2. Mexico
      • 8.2.6.2.1. By Software
      • 8.2.6.2.2. By Modality
      • 8.2.6.2.3. By Imaging
      • 8.2.6.2.4. By Application
      • 8.2.6.2.5. By End User
      • 8.2.6.3. Argentina
      • 8.2.6.3.1. By Software
      • 8.2.6.3.2. By Modality
      • 8.2.6.3.3. By Imaging
      • 8.2.6.3.4. By Application
      • 8.2.6.3.5. By End User
      • 8.2.6.4. Peru
      • 8.2.6.4.1. By Software
      • 8.2.6.4.2. By Modality
      • 8.2.6.4.3. By Imaging
      • 8.2.6.4.4. By Application
      • 8.2.6.4.5. By End User
      • 8.2.6.5. Rest of LATAM
      • 8.2.6.5.1. By Software
      • 8.2.6.5.2. By Modality
      • 8.2.6.5.3. By Imaging
      • 8.2.6.5.4. By Application
      • 8.2.6.5.5. By End User

9. Middle East & Africa Medical Image Analysis Software Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Software
    • 9.2.2. By Modality
    • 9.2.3. By Imaging
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
      • 9.2.6.1. Saudi Arabia
      • 9.2.6.1.1. By Software
      • 9.2.6.1.2. By Modality
      • 9.2.6.1.3. By Imaging
      • 9.2.6.1.4. By Application
      • 9.2.6.1.5. By End User
      • 9.2.6.2. UAE
      • 9.2.6.2.1. By Software
      • 9.2.6.2.2. By Modality
      • 9.2.6.2.3. By Imaging
      • 9.2.6.2.4. By Application
      • 9.2.6.2.5. By End User
      • 9.2.6.3. Qatar
      • 9.2.6.3.1. By Software
      • 9.2.6.3.2. By Modality
      • 9.2.6.3.3. By Imaging
      • 9.2.6.3.4. By Application
      • 9.2.6.3.5. By End User
      • 9.2.6.4. Kuwait
      • 9.2.6.4.1. By Software
      • 9.2.6.4.2. By Modality
      • 9.2.6.4.3. By Imaging
      • 9.2.6.4.4. By Application
      • 9.2.6.4.5. By End User
      • 9.2.6.5. South Africa
      • 9.2.6.5.1. By Software
      • 9.2.6.5.2. By Modality
      • 9.2.6.5.3. By Imaging
      • 9.2.6.5.4. By Application
      • 9.2.6.5.5. By End User
      • 9.2.6.6. Nigeria
      • 9.2.6.6.1. By Software
      • 9.2.6.6.2. By Modality
      • 9.2.6.6.3. By Imaging
      • 9.2.6.6.4. By Application
      • 9.2.6.6.5. By End User
      • 9.2.6.7. Algeria
      • 9.2.6.7.1. By Software
      • 9.2.6.7.2. By Modality
      • 9.2.6.7.3. By Imaging
      • 9.2.6.7.4. By Application
      • 9.2.6.7.5. By End User
      • 9.2.6.8. Rest of MEA
      • 9.2.6.8.1. By Software
      • 9.2.6.8.2. By Modality
      • 9.2.6.8.3. By Imaging
      • 9.2.6.8.4. By Application
      • 9.2.6.8.5. By End User

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Medical Image Analysis Software Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Medical Image Analysis Software Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Toshiba Medical Systems Corp.
  • 12.2. Bruker Corp.
  • 12.3. Xinapse Systems Ltd.
  • 12.4. Esaote, Inc.
  • 12.5. ClaroNAv, Inc.
  • 12.6. Merge Healthcare Inc.
  • 12.7. Aquilab GmbH
  • 12.8. Spacelabs Healthcare, Inc.
  • 12.9. MIM Software Inc.
  • 12.10. Carestream Health, Inc.
  • 12.11. Agfa-Gevaert Corp.
  • 12.12. Philips Healthcare
  • 12.13. Siemens Healthineers
  • 12.14. GE Healthcare
  • 12.15. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations